Besides, hyaluronan (HA) has been shown to inhibit the toll-like receptor (TLR) 4 activity to downregulate PTN level in a Th1-type autoimmune disease model, implicating PTN as a TLR4-responsive gene (38). The gene discussed is PTN; the disease is autoimmune disease.